Statistics for Engineering a CD19-Based Bispecific Molecule for CAR T Cell Therapy
Total visits
views | |
---|---|
Engineering a CD19-Based Bispecific Molecule for CAR T Cell Therapy | 78 |
Total visits per month
views | |
---|---|
February 2024 | 0 |
March 2024 | 3 |
April 2024 | 2 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
File Visits
views | |
---|---|
Schrack_umn_0130M_19812.pdf | 223 |
Top country views
views | |
---|---|
United States | 38 |
China | 10 |
Germany | 3 |
Taiwan | 3 |
Canada | 2 |
Egypt | 2 |
United Kingdom | 2 |
Hong Kong SAR China | 2 |
Ireland | 2 |
Switzerland | 1 |
Chile | 1 |
Ethiopia | 1 |
Indonesia | 1 |
India | 1 |
Iran | 1 |
Japan | 1 |
Mauritius | 1 |
Malaysia | 1 |
Poland | 1 |
Russia | 1 |
Saudi Arabia | 1 |
Singapore | 1 |
Top city views
views | |
---|---|
Ashburn | 9 |
Boardman | 4 |
Ann Arbor | 3 |
Des Moines | 3 |
Zhengzhou | 3 |
Central | 2 |
Cologne | 2 |
Dublin | 2 |
Minneapolis | 2 |
Woodford Green | 2 |
Alexandria | 1 |
Beijing | 1 |
Boston | 1 |
Cambridge | 1 |
Chapel Hill | 1 |
Chongqing | 1 |
Duarte | 1 |
Durham | 1 |
Elmsford | 1 |
Mount Prospect | 1 |
Philadelphia | 1 |
Puchong Batu Dua Belas | 1 |
San Francisco | 1 |
Sarnia | 1 |
Singapore | 1 |
Taichung | 1 |
Toronto | 1 |
Vladivostok | 1 |
Zurich | 1 |